Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT05388006 · RECRUITING
Trial details
- NCT number
- NCT05388006
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-05
- Primary completion
- 2027-02-22
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.